𝘒𝘢𝘶𝘷𝘦𝘳𝘺 𝘏𝘰𝘴𝘱𝘪𝘵𝘢𝘭 𝘈𝘭𝘸𝘢𝘳𝘱𝘦𝘵 𝘐𝘯𝘵𝘳𝘰𝘥𝘶𝘤𝘦𝘴 𝘊𝘈𝘙-𝘛 𝘊𝘦𝘭𝘭 𝘛𝘩𝘦𝘳𝘢𝘱𝘺 – 𝘈 𝘙𝘦𝘷𝘰𝘭𝘶𝘵𝘪𝘰𝘯𝘢𝘳𝘺 𝘓𝘦𝘢𝘱 𝘪𝘯 𝘊𝘢𝘯𝘤𝘦𝘳 𝘛𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵

Chennai, 15th May 2025 — Kauvery Hospital, Alwarpet, a leading multi-specialty healthcare provider in Chennai, has launched Chimeric Antigen Receptor T-cell (CAR-T) therapy, a major development in the field of cancer care. With this launch, Kauvery becomes one of the few hospitals in India offering this advanced form of immunotherapy for select blood cancers.

(Team) Dr. Preethi, Consultant, Medical Oncologist, Kauvery Hospital, Alwarpet; Dr. Mahesh Kumar.K, Kauvery Hospital, Alwarpet, Medical superintendent; Dr. Iyappan Ponnuswamy,Medical Director,Kauvery Hospital, Chennai; Dr. Hasmukh Jain,Professor Medical Oncologist ,Tata Memorial Centre; Dr. Anitha Ramesh, Consultant, Medical Oncologist, Kauvery Hospital, Alwarpet; Mr. Shirish Arya, CEO, IMMUNO ACT; Dr.A N Vaidhyswaran, Director of Radiation Oncologist, Kauvery Hospital, Alwarpet; Dr. Suresh Kumar, Consultant, Medical Oncologist, Kauvery Hospital, Alwarpet; Dr. Arshad Raja, Consultant Oncologist, Kauvery Hospital, Alwarpet

CAR-T therapy is a type of immunotherapy that uses a patient’s own immune cells, called T cells, to fight cancer. Doctors take these T cells from the patient’s own blood and modify them in a lab so they can better recognize and attack cancer cells. After this modification, the reengineered T cells are subsequently infused into the patient’s body, where they locate and eliminate the cancer cells.

Youtube shorts 👇

This treatment is mainly used for certain blood cancers like acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL), especially when patients who have not responded to conventional therapies. CAR-T therapy offers a more targeted and personalized approach, helping patients whose cancer has returned or resisted standard therapies. Because the modified T cells can multiply and stay active in the body, they provide ongoing protection against cancer relapse.

“CAR-T therapy changes how we treat hematologic cancers,” said Dr. Arshad Raja, Consultant Hemato-Oncologist and Bone Marrow Transplant Physician at Kauvery Hospital. “It redefines our approach to blood cancer treatment with this advancement now available locally, we are empowering patients in India with world-class, precision-targeted care that was once out of reach.”

According to the Indian Council of Medical Research (ICMR), India records over 1.4 million new cancer cases annually, with hematologic cancers comprising a significant portion. CAR-T therapy provides a vital option when standard chemotherapy or transplants fail. By making this therapy available in Chennai, Kauvery Hospital expands access to patients across South India who would otherwise need to seek care in metro cities or abroad.

“Bringing CAR-T therapy to our hospital reflects our ongoing focus on introducing new treatment options that meet global standards,” said Dr. Aravindan Selvaraj, Executive Director and Co-Founder of Kauvery Group of  Hospitals. “The launch of CAR-T therapy marks a bold step into the future of medicine. It reflects our passion for innovation, our pursuit of excellence, and our mission to change lives for the better.”

The launch is expected to benefit patients in Tamil Nadu and neighbouring states who previously had limited access to this form of therapy. With a team of experienced oncologists and a dedicated cellular therapy unit, the hospital is prepared to deliver this specialized treatment under rigorous clinical protocols.

****